Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
Targeting the Accomplices of MYC in MYC-driven Medulloblastoma |
Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D. |
Innovation Grants |
2014 |
California |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
Application of Epigenetic Markers for Early Detection of Childhood Leukemia.
|
University of California San Francisco / Sheng Zhong |
Epidemiology Grants |
2008 |
California |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2012 |
California |
Novel Resilience Genes Required for Cerebellum Development and Medulloblastoma Survival |
University of California San Francisco / Stephen Fancy, PhD, DVM |
Innovation Grants |
2023 |
California |
Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |